Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lyra Therapeutics ( (LYRA)) has provided ...
Lyra Therapeutics, Inc. (NASDAQ:LYRA) released results on Monday from the ENLIGHTEN 2 Phase 3 trial of LYR-210 in adult patients with Chronic Rhinosinusitis (CRS). The ENLIGHTEN 2 trial met its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback